At this moment, the diagnostic tools for prostate cancer are digital rectal examination (DRE), prostate-specific antigen (PSA) value, prostate biopsy-Gleason score and prostate magnetic resonance imagining (MRI) [1]. The gene discussed is KLK3; the disease is prostate carcinoma.